ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 794

How Many Steps/Day Are Associated with a Community Level Gait Speed Among Older Adults with or At High Risk of Knee OA?

Daniel K. White1, Roger Fielding2, Tuhina Neogi3, Michael P. Lavalley4, K. Douglas Gross5, Michael C. Nevitt6, C.E. Lewis7, James Torner8 and Catrine Tudor-Locke9, 1Department of Physical Therapy, University of Delaware, Newark, DE, 2Nutrition, Exercise Physiology and Sarcopenia Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, 3Boston University School of Medicine, Boston, MA, 4Biostatistics, Boston University School of Public Health, Boston, MA, 5Physical Therapy, MGH Institute of Health Professions, Boston, MA, 6Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 7University of Alabama, Birmingham City, AL, 8Epidemiology, University of Iowa, Iowa City, Iowa City, IA, 9Pennington Biomedical Research Center, Baton Rouge, LA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Osteoarthritis and physical activity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Foot and Gait Disorders

Session Type: Abstract Submissions (ARHP)

Background/Purpose: While recommended levels of physical activity associated with reducing the risk of poor health outcomes are well known, it is unclear what minimal level of walking is associated with functional benchmarks specific to older adults.  The purpose of this study was to examine the minimal number of steps/day associated with walking at a community level gait speed in older adults with or at high risk of knee osteoarthritis (OA).

Methods:   The Multicenter Osteoarthritis Study (MOST) is an NIH funded longitudinal study of older men and women who have or are at high risk for knee OA.  Participants at the 60-month visit wore a StepWatch Activity Monitor to record walking behavior over 7 days.  Usual gait speed (m/s) during a 20 meter walk was determined at the same clinic visit.  Walking behavior (steps/day) that best discriminated a gait speed of ≥1.2 m/s (speed needed to cross the street) was determined using a Receiver Operator Curve (ROC).  Sensitivity, specificity, and positive predictive value (PPV) was calculated to quantify how well the identified steps/day predicted walking at least 1.2 m/s.

Results:   Among 1,757 participants considered (67 ± 8 yrs, BMI 31 ± 6 kg/m2, female 59%), mean walking behavior was 7,094 ± 2,917 steps/day [range 640 – 21,593] and mean gait speed was 1.22 m/s ± 0.21 [range 0.4 – 2.1].  Walking at least 6,500 steps/day discriminated meeting a gait speed of ≥1.2 m/s (sensitivity = 70%, specificity = 64%, PPV = 71%).

Conclusion:   Most older adults with or at high risk of knee OA who walk at least 6,500 steps/day have gait speeds associated with walking in the community.  While further confirmation is needed, at present clinicians may consider setting a goal of 6,500 steps/day as a minimal level of walking for older adults with or at high risk of knee OA. 


Disclosure:

D. K. White,
None;

R. Fielding,
None;

T. Neogi,
None;

M. P. Lavalley,
None;

K. D. Gross,
None;

M. C. Nevitt,
None;

C. E. Lewis,
None;

J. Torner,
None;

C. Tudor-Locke,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/how-many-stepsday-are-associated-with-a-community-level-gait-speed-among-older-adults-with-or-at-high-risk-of-knee-oa/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology